Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bo... ( MOUNTAIN VIEW Calif. Oct. 14 /- B...)

Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing

Date:10/14/2008

MOUNTAIN VIEW, Calif., Oct. 14 /PRNewswire/ -- Based on its recent analysis of the bone healing market, Frost & Sullivan recognizes ISTO Technologies, Inc. with the 2008 North American Frost & Sullivan Award for Product Innovation for its novel InQu(R) Bone Graft Extender and Substitute scaffold. InQu represents the first commercial product launched by the company using its proprietary biomaterial-based platform technology.

Although spinal fusions and other orthopedic intervention methods are routinely used to eliminate back pain, surgeons are still unsure about the right choice in bone grafting materials. While autologous grafts have traditionally been considered the "gold standard" in treatment, the pain associated with harvesting autologous bone, along with an increase in operation and recovery times, and high rates of complications including donor site morbidity have made a case for alternative treatments.

"ISTO Technologies' InQu Bone Graft Extender and Substitute brings to the forefront the strengths and biological attributes of two reliable, safe, and effective biomaterials: Poly lactide-co-glycolide (PLGA) and hyaluronic acid (HyA)," explains Frost & Sullivan Research Analyst Pramodh Ishwarakrishnan. "The unique InQu scaffold creates a microenvironment that is both biocompatible and conducive to new bone formation."

These two major components of the scaffold have specific contributions to the overall healing process. PLGA, while giving the three-dimensional structure to InQu, also provides a reliable resorption rate at the site of implantation. HyA has been shown to play a critical role in tissue regeneration and repair, apart from promoting the migration, proliferation, and differentiation of osteogenic cells during the early stages of normal bone formation.

"The ideal combination of PLGA and HyA offers the advantages of superior cohesiveness, molding properties, handling characteristics and consistently predictable result
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy

Post Your Comments:

(Date:2/9/2010)... 9 Reportlinker.com announces ... is available in its catalogue: ,, ... Market (Growth Opportunities, Competitive Analysis and ... http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive-Analysis-and-Competitor-Profiles.html ,, Clinical laboratories are ... industry. It is estimated that ...

(Date:2/9/2010)... 9 endpoint Clinical ( www.endpointclinical.com ... Web Response (IWR) systems, announced today that PULSE, ... design and deploy clinical trial Integrated Response Technology ... time of clinical trials. This time and cost ... programs so developers do not have to spend ...

(Date:2/9/2010)... Feb. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., ... and supplier of,modernized traditional Chinese medicine ("TCM") and ... announced that it expects operational benefits,from the recently ... Medicine,and Medical Services by the Chinese government. ,, ... 2009 , the Chinese National Development and Reform,Commission, ...

(Date:2/9/2010)... of $500,000 to prevent crop damage by nematodes as the ... ... (PRWEB) February 9, 2010 -- Divergence, ... Small Business Innovation Research (SBIR) grants totaling $500,000, along with ... support advancement of the company’s innovative work to prevent crop ...

[0] Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)[0] endpoint Saves Money and Time for Medical Research Teams Through PULSE [0] Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services [0] New Funding Validates Importance of Divergence's Work on Nematodes

... professor Apparao Rao and his team are researching nano-scale cantilevers ... toxic chemicals or gases in the air. Put them into ... real-time chemical alerts in battle, in industry, in health care ... small devices to do this work has been something we,ve ...

... 12 /Xinhua-PRNewswire-FirstCall/ -- China Biologic,Products, Inc. (OTC Bulletin ... leading plasma-based pharmaceutical companies in the,People,s Republic of ... quarter ended September 30, 2008., Third ... year-over-year to $13.8 million -- Gross profit ...

... Neb., Nov. 12 Protease substrates provide a,sensitive ... inhibitors,and screen compound collections for discovery of drug ... Protease Substrates:,IRDye 800CW/QC-1 HIV-1, IRDye 800CW/QC-1 BACE, and ... intrinsic fluorescence due to self-quenching,of the conjugated dye ...

Clemson researchers advance nanoscale electromechanical sensors China Biologic Products Reports Strong Third Quarter 2008 Results LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates

(Date:2/9/2010)... genetic mutations cause disease. What are largely unknown are ... the molecular level, giving rise to clinically observable symptoms ... led by scientists at the Buck Institute for Age ... of many inherited genetic diseases. These predictions involve tens ... to the creation of a web-based tool available to ...

(Date:2/9/2010)... Barrow Neurological Institute at St. Joseph,s Hospital and ... advancement of a new category of painkillers, called ... transient receptor potential vannilloid-1 (TRPV1) channel, which is ... hotness from hot peppers. However, clinical trials have ... fever-like rise in body temperature. , Research has ...

(Date:2/9/2010)... , Feb. 9 Pacific Biomarkers, ... biomarker services to support pharmaceutical and laboratory diagnostic manufacturers ... that it has scheduled an investor conference call for ... ) on Friday, February 12, 2010 to ... and first half of FY2010. The Company intends to ...

Breaking Biology News(10 mins):Comprehensive study using bioinformatics predicts the molecular causes of many genetic diseases 2 Comprehensive study using bioinformatics predicts the molecular causes of many genetic diseases 3 New era of pain drugs advanced by Barrow researcher 2 Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010 2 Covance to Present at the 28th Annual J P Morgan Healthcare Conference 7299 1 VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High Definition Broadcast Events 7296 1 VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High Definition Broadcast Events 7296 2 VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High Definition Broadcast Events 7296 3 Ancient Egyptian cosmetics 3A Magical makeup may have been medicine for eye disease 64327 1

[0] Comprehensive study using bioinformatics predicts the molecular causes of many genetic diseases [0] New era of pain drugs advanced by Barrow researcher [0] Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010

... enhances the activity of a key brain cell receptor ... deficits in mice engineered to have pathological hallmarks of ... both of the pathologies--the brain-clogging buildup of protein "amyloid ... inside the cells. , In an article in ...

... people may be more sensitive to pain than people who ... older adults who completed the study had osteoarthritis of the ... the knees. , Participants were given a mild electrical stimulation ... stimulus was given before and after the participants took part ...

... at the top of the marine food chain, albatrosses ... in their bodies. A new study has found dramatic ... species that forage in different areas of the North ... DDT have increased in both species over the past ...

Other Biology News:Experimental drug reverses key cognitive deficits, pathology in Alzheimer's 2 Obese people are more sensitive to pain, suggests study 2 Obese people are more sensitive to pain, suggests study 3 Albatross study shows regional differences in ocean contamination 2 Albatross study shows regional differences in ocean contamination 3

Experimental drug reverses key cognitive deficits, pathology in Alzheimer's Obese people are more sensitive to pain, suggests study Albatross study shows regional differences in ocean contamination

Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....

... U.S. sourced, ideal for those ... Low hemoglobin; Endotoxin: < 1.0 ... US origin; U.S. sourced, ideal ... uncompromising quality. Low hemoglobin Endotoxin: ...

Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...

Fetal Calf Serum Replacement (Bistec) serum...

Biology Products:

Rabbit Anti-Human YIPF6 Polyclonal Antibody, Unconjugated from Atlas Antibodies Bovine Calf Serum - 500mL from GeneTex Chicken Anti-Bacterial ytzF Polyclonal Antibody, Unconjugated from Abcam Fetal Calf Serum Replacement (Bistec) serum from Equitech-Bio

Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bo...( MOUNTAIN VIEW Calif. Oct. 14 /- B...)